Operating

Other Current Liabilities

Kailera Therapeutics Other Current Liabilities increased by 788.7% to $9.38M in Q1 2026 compared to the prior quarter.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2025
Last reportedQ1 2026May 26, 2026

How to read this metric

An increase acts as a source of cash, while a decrease acts as a use of cash as these obligations are settled.

Detailed definition

This tracks the change in miscellaneous current liabilities, such as accrued wages, interest, or other short-term obliga...

Peer comparison

Varies by company based on the nature of their specific accrual categories.

Metric ID: operating_increase_decrease_in_other_accounts_payable_an_5b9da7

Historical Data

2 periods
 Q1 '25Q1 '26
Value$1.06M$9.38M
QoQ Change—+788.7%
YoY Change—+788.7%
Range$1.06M – $9.38M
Avg YoY Growth+788.7%
Median YoY Growth+788.7%

Other Current Liabilities at Other Companies

Cigna logo
CignaCIView metric
Take-Two Interactive Software logo
Take-Two Interactive SoftwareTTWOView metric
Colgate-Palmolive logo
Colgate-PalmoliveCLView metric
Simon Property Group logo
Simon Property GroupSPGView metric
Waste Management logo
Waste ManagementWMView metric
Carvana logo
CarvanaCVNAView metric

Frequently Asked Questions

What is Kailera Therapeutics 's other current liabilities?
Kailera Therapeutics (KLRA) reported other current liabilities of $9.38M in Q1 2026.
What does other current liabilities mean?
The change in cash impact from miscellaneous short-term obligations other than trade payables.